CoChat

Maternal Serum Prolactin and Prediction of Postpartum β-Cell Function and Risk of Prediabetes/Diabetes

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The insulin resistance of mid- to late pregnancy poses a physiologic stress test for the pancreatic β-cells, which must respond by markedly increasing their secretion of insulin. This response is achieved through an expansion of β-cell mass induced by the hormones prolactin and human placental lactogen (HPL). Conversely, the furan fatty acid metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) has recently emerged as a negative regulator of β-cell function in pregnancy. Given their respective roles in the β-cell response to the stress test of gestation, we hypothesized that antepartum prolactin, HPL, and CMPF may relate to a woman’s underlying glucoregulatory physiology and hence to her metabolic status after pregnancy. RESEARCH DESIGN AND METHODS: Three hundred and sixty-seven women underwent measurement of fasting serum prolactin, HPL, and CMPF in the late-2nd/early-3rd trimester, followed by an oral glucose tolerance test (OGTT) at 3 months postpartum that enabled assessment of glucose tolerance, insulin sensitivity/resistance, and β-cell function (Insulin Secretion-Sensitivity Index-2 [ISSI-2]). RESULTS: The postpartum OGTT identified 301 women with normal glucose tolerance (NGT) and 66 with prediabetes or diabetes. Serum prolactin in pregnancy was higher in women with postpartum NGT compared with those with postpartum prediabetes/diabetes (mean 98.2 vs. 80.2 ng/mL, P = 0.0003), whereas HPL and CMPF did not differ between the groups. On multiple linear regression analyses, antepartum prolactin was an independent determinant of postpartum ISSI-2 (β = 0.0016, t = 2.96, P = 0.003). Furthermore, higher serum prolactin in pregnancy independently predicted a lower risk of postpartum prediabetes/diabetes (odds ratio 0.50, 95% CI 0.35–0.72, P = 0.0002). CONCLUSIONS: Serum prolactin in pregnancy predicts postpartum β-cell function and risk of prediabetes/diabetes.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc16-0043

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Cited by

See all 64

Metadata

Authors
Retnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B.
Affiliations
  • Mount Sinai Hospital (CA)
  • St. Michael's Hospital (CA)
Corresponding author
Retnakaran, Ravi
Venue
Diabetes Care
Published
2016-04-26
Volume
39
Issue
7
Pages
1250-1258
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2343756654
Cited by
64
References
39
Citations by year
2026: 3 · 2025: 3 · 2024: 11 · 2023: 6 · 2022: 11 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 2
FWCI
7.75
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research (CIHR MOP-84206)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
prediabetes, diabetes risk, human placental lactogen, CMPF, furan fatty acids, insulin resistance in pregnancy, oral glucose tolerance test, postpartum glucose tolerance
MeSH terms
Adult, Blood Glucose, Female, Furans, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Placental Lactogen, Prediabetic State, Predictive Value of Tests, Pregnancy, Pregnancy Complications, Pregnancy Trimester, Third, Prolactin, Propionates, Prospective Studies, Regression Analysis, Risk Factors, Diabetes, Gestational, Glucose Intolerance, Postpartum Period, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.